Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1465 | 2017 |
Breast Cancer Risk Genes-Association Analysis in More than 113,000 Women. L Dorling, S Carvalho, J Allen, A González-Neira, C Luccarini, ... The New England journal of medicine 384 (5), 428-439, 2021 | 757 | 2021 |
Prediction of breast cancer risk based on profiling with common genetic variants N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ... JNCI: Journal of the National Cancer Institute 107 (5), 2015 | 698 | 2015 |
A common coding variant in CASP8 is associated with breast cancer risk A Cox, AM Dunning, M Garcia-Closas, S Balasubramanian, MWR Reed, ... Nature genetics 39 (3), 352-358, 2007 | 695 | 2007 |
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer K Michailidou, J Beesley, S Lindstrom, S Canisius, J Dennis, MJ Lush, ... Nature genetics 47 (4), 373-380, 2015 | 686 | 2015 |
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 587 | 2015 |
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 406 | 2017 |
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses H Zhang, TU Ahearn, J Lecarpentier, D Barnes, J Beesley, G Qi, X Jiang, ... Nature genetics 52 (6), 572-581, 2020 | 382 | 2020 |
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 327 | 2018 |
Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 320 | 2015 |
Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 264 | 2019 |
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ... Journal of medical genetics 53 (12), 800-811, 2016 | 261 | 2016 |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer L Wu, W Shi, J Long, X Guo, K Michailidou, J Beesley, MK Bolla, XO Shu, ... Nature genetics 50 (7), 968-978, 2018 | 236 | 2018 |
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer KS Purrington, S Slager, D Eccles, D Yannoukakos, PA Fasching, P Miron, ... Carcinogenesis 35 (5), 1012-1019, 2014 | 220 | 2014 |
Cancer risks associated with BRCA1 and BRCA2 pathogenic variants S Li, V Silvestri, G Leslie, TR Rebbeck, SL Neuhausen, JL Hopper, ... Journal of Clinical Oncology 40 (14), 1529, 2022 | 196 | 2022 |
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. L Fachal Vilar, H Aschard, J Beesley, D Barnes, J Allen, S Kar, K Pooley, ... Springer Nature, 2020 | 172* | 2020 |
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... Nature genetics 52 (1), 56-73, 2020 | 172 | 2020 |
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 AM Dunning, K Michailidou, KB Kuchenbaecker, D Thompson, JD French, ... Nature genetics 48 (4), 374-386, 2016 | 165 | 2016 |
Height and breast cancer risk: evidence from prospective studies and Mendelian randomization B Zhang, XO Shu, RJ Delahanty, C Zeng, K Michailidou, MK Bolla, ... Journal of the National Cancer Institute 107 (11), djv219, 2015 | 161 | 2015 |
Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients MU Rashid, A Zaidi, D Torres, F Sultan, A Benner, B Naqvi, AR Shakoori, ... International journal of cancer 119 (12), 2832-2839, 2006 | 158 | 2006 |